Case Type: Mergers & Acquisitions

Concho Resources, Inc. (CXO) relating to its proposed acquisition by ConocoPhillips. Under the terms of the agreement, Concho shareholders will receive 1.46 shares of ConocoPhillips for each share of Concho they own.

BioSpecifics Technologies Corp. (BSTC) relating to its proposed acquisition by Endo International PLC. Under the terms of the agreement, BioSpecifics shareholders will receive $88.50 per share in cash.

MYOS RENS Technology, Inc. (MYOS) relating to its merger with MedAvail, Inc. Under the terms of the agreement, MYOS shareholders receive a dividend of a MYOS subsidiary, and MYOS shareholders will own only 3.5% of the new combined company. The remaining 96.5% of the new entity will be owned by MedAvail’s security holders and new … Read more

PropTech Acquisition Corp. (PTAC) in connection with the business combination with Porch.com, Inc. (“Porch”).

MobileIron, Inc. (MOBL) relating to its proposed acquisition by Ivanti, Inc. Under the terms of the agreement, MobileIron shareholders will receive $7.05 in cash per share.

Standard AVB Financial Corp. (STND) relating to its proposed acquisition by Dollar Mutual Bancorp. Under the terms of the agreement, Standard shareholders will receive $33.00 in cash per share.

Eidos Therapeutics, Inc. (EIDX) relating to its proposed acquisition by BridgeBio Pharma, Inc. Under the terms of the agreement, Eidos’ shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share.

WPX Energy, Inc. (WPX) relating to its proposed acquisition by Devin Energy Corporation (“DVN”). Under the terms of the agreement, WPX shareholders will receive 0.5165 shares of DVN for each share of WPX common stock that they own.

Eaton Vance Corp. (EV) relating to its proposed acquisition by Morgan Stanley. Under the terms of the agreement, EV shareholders have the option to receive (i) $28.25 in cash and 0.5833 of a share of Morgan Stanley common stock; or, subject to a proration and adjustment mechanism, (ii) an amount of all cash; or (iii) … Read more

AMAG Pharmaceuticals, Inc. (AMAG) relating to its acquisition by Covis Group S.à.r.l. Under the terms of the agreement, AMAG shareholders shall be entitled to receive $13.75 in cash for each share of AMAG common stock owned.